There is no brand name associated with this product
GLP-1 receptor agonists are increasingly favored for their ability to promote sustained weight reduction, improve glycemic control, and deliver cardiovascular benefitsmaking them superior to many legacy obesity treatments
In obese mice fed a high fat (60%) diet after GB-IL, dramatic reductions in food intake, body weight, hepatic steatosis and adiposity were concurrent with increases in serum bile acids, significantly improved oral glucose tolerance and changes in the gut microbiome
We present this article in accordance with the Narrative Review reporting checklist (available at Methods A search of the literature was conducted on OVID (1947May 2025) using the terms [papilledema OR intracranial hypertension OR idiopathic intracranial hypertension OR brain pseudotumor] AND [glucagon like peptide 1 OR glucagon like peptide 1 receptor agonist OR semaglutide OR exendin 4 OR liraglutide OR tirzepatide]
Take 1 to 4 capsules daily with or without food.
MZ, MN-S, and OA extracted the data and conducted the analyses
